FORINGEN
RESEARCH NETWORK FOR INFECTOGENOMICS
The association
Despite increasing medical progress, infectious diseases continue to pose a substantial threat to the human population. New types of pathogens emerge, chronic infections advance (increase) and the rise of multi-resistant pathogens challenges modern medicine as they evade established treatment methods and seem to be always one step ahead. Today scientists have a much deeper insight how pathogens mutate and adapt to the host. Due to genomic research the characterization of genomic sequences of numerous pathogens could be achieved in the past ten years. Surprisingly, most pathogens seem to have a higher potential to adapt to surrounding conditions than expected before. Genomic research describes an infection as battle between the host genome and the permanently altering viral genome. Similarly, this can be observed for most malignancies. Here the host genome is as well not able to defeat the transformed genome of the tumor cell. Due to modern methods of genomic and proteomic research scientists gain completely new insights in the interaction between pathogens and host. Based on these new findings the research network FORINGEN aims at improving diagnostics, therapy and prevention of infectious diseases. Hereby researchers from the field of infection biology at the universities of Würzburg, Erlangen-Nuremberg, Regensburg, Greifswald and Munich work in tight collaboration with partners form the biotech-industry. The research cooperation is funded by the Bavarian Research Foundation with 1,75 Mio. € for 3 years, another 1,85 Mio. € are provided by the industrial partners.
Organisation
Technician
Scientists
- Britta Albertzarth
- Simon Bredl
- Dr. Joachim Fensterle
- Dr. Volker Fingerle
- PD Dr. Wolfgang Fischer
- Torben Friedrich
- Martin Heisig
- Christine Henke
- Dr. Sarah Leonhard
- Dr. Karin Metzner
- Dr. Julia Niefnecker
- Daniela Nowack
- Dr. Knut Ohlsen
- Dr. Christian Schetter
- Dr. Ulrike Schulte-Spechtel
- Stefan Sörgel
- Dipl. Ing. Jörg Votteler
- Dr. Nina Wantia
- Dr. Jens Wild
Industy partner
Head of Research Division
- Dr. Ulrich Dobrindt
- PD Dr. Ivaylo Gentschev
- PD Dr. Dr. Jürgen Haas
- Professor Dr. Rainer Haas
- Dr. Michael Hogardt
- Professor Dr. Ulrich Koszinowski
- Professor Dr. Thomas Miethke
- Professor Dr. Ulf R. Rapp
- Professor Dr. Ulrich Schubert
- Professor Dr. Dr. h.c. Hermann Wagner
- Prof. Dr. Ralf Wagner
- Professor Dr. Bettina Wilske
- PD Dr. Wilma Ziebuhr
General Management
Second Spokesperson
Partner
Projects
-
Diagnostics and Therapeutics
- DT-1 Improvement of a DNA array for diagnostics of clinically relevant enterobacteria
- DT-3 H. pylori pathodiagnostics
- DT-4 Genome-based identification of targets specific for bovine Staphylococcus aureus isolates
- DT-5 Development of a Microsphere based multiplex serology for differential diagnosis in reactive arthritis and lyme arthritis.
- DT-6 Antibiotic resistance of Pseudomonas aeruginosa from Cystic Fibrosis patients
- DT-8 HIV-1 Vpr as a target for antiviral therapy
- Vaccines and Adjuvants
Contact
Dr. Sabine Schmoldt
LMU München
Max von Pettenkofer-Institut, Bakteriologie
Pettenkoferstr. 9a
80336 München
Telefon: +49-89-5160 5433
Email: <link>foringen@lmb.uni-muenchen.de